2023年

Watanabe M, Hatsuse H, Nagao K, Nakashima M, Uchimaru K, Otsu M, Miyazaki K, Horie R.
CD30 induces Reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines.
Cancer Sci, 2023 in press.🆕

Koseki A, Araya N, Yamagishi M, Yamauchi J, Yagishita N, Takao N, Takahashi K, Kunitomo Y, Honma D, Araki K, Uchimaru K, Sato T, Yamano Y.
EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy.
Front Microbiol, 2023 in press.🆕

Kuramitsu M, Momose H, Uchida Y, Ishitsuka K, Kubota R, Tokunaga M, Utsunomiya A, Hashikura Y, Umekita K, Nosaka K, Koh Ki-Ryang , Nakamura H, Sagara Y, Sobata R, Satake Ma, Nagata K, Hasegawa Y, Sasaki D, Hasegawa H, Sato T, Yamano Y, Hiraga K, Tezuka K, Ikebe E, Matsuoka S, Okuma K, Watanabe T, Miura K, and Hamaguchi I.
Performance evaluation of ESPLINE HTLV-I/II, a newly developed rapid immunochromatographic antibody test, for different diagnostic situations.
Journal of Clinical Microbiology, 2023 in press.

Nakashima M and Uchimaru K.
CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Int J Mol Sci, 24(10):8731, 2023.
doi.org/10.3390/ijms24108731

Nakashima M, Utsunomiya A, Watanabe T, Horie R, Uchimaru K.
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.
Cancer Sci, 114(4):1556-1568, 2023.
doi: 10.1111/cas.15706.

Sato T, Yamauchi J, Yagishita N, Araya N, Takao N, Ohta Y, Inoue E, Takahashi M, Yamagishi M, Suzuki Y, Uchimaru K, Matsumoto N, Hasegawa Y, Yamano Y.
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
Brain, 2023 in press.
doi: 10.1093/brain/awad139

Shiraishi M, Kamo T, Kumazawa R, Sasaki N, Isahaya K, Akiyama H, Furusawa Y, Onodera R, Fernandez J, Otuska M, Yamano Y.
A multicenter, prospective, observational study to assess the satisfaction of an integrated digital platform of online medical care and remote patient monitoring in Parkinson’s disease.
Neurology and Clinical Neuroscience, 11(3):109-177, 2023.
doi:10.1111/ncn3.12709.

Uchino K, Soga K, Shinohara K, Imai T, Motohashi I, Okuma H, Yamano Y.
Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019.
Intern. Med, 2023 in press.
doi.org/10.2169/internalmedicine.0394-22

Fukuta T, Tanaka T, Hashimoto T, Isahaya K, Kubo Y, Yamano Y, Satomi K, Hiraoka N, Shirakawa N, Arakawa A, Ogawa C, Nishimura N, Aoki J, Ito A, Inamoto Y, Kim SW, Fukuda T.
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Int J Hematol,2023 in press.
doi: 10.1007/s12185-023-03539-5

浅田 隆太, 一村 昌彦, 今井 晶子, 岩田 香苗, 太田 有紀, 菊地 佳代子, 今野 浩一, 高木 佳子, 寺田 智子, 萩森 奈央子, 堀部 恵梨佳, 丸本 芳雄.
現地開催！スタディマネジャー/プロジェクトマネジャーつながり対話会.
臨床薬理、54(2):85-88, 2023. 🆕
doi.org/10.3999/jscpt.54.2_85

山野 嘉久.
特集にあたって.
神経治療学, 40(1):7, 2023年4月.
https://doi.org/10.15082/jsnt.40.1_7

八木下 尚子, 山野 嘉久.
Human T–cell leukemia virus type I関連脊髄症患者レジストリ「HAMねっと」.
神経治療学, 40(1):28-31, 2023年4月.
https://doi.org/10.15082/jsnt.40.1_28

鷹尾 直誠, 佐藤 知雄, 山内 淳司, 八木下 尚子, 堀部 恵梨佳, 山野 嘉久.
HTLV-1関連脊髄症（HAM）診療ガイドライン2019」の活用実態および内容の評価に関する全国アンケート調査.
臨床神経学, 2023 in press.

星野 俊，伊藤 葵，清水 高弘，秋山 久尚，山野 嘉久.
延髄梗塞を合併した帯状疱疹性脊髄炎の 1 例.
BRAIN and NERVE, 75(3):269-273, 2023.

鷹尾 直誠, 山野 嘉久.
HTLV-1関連脊髄症（HAM）.
CLINICAL NEUROSCIENCE, 41(1):122-125, 2023年1月.